Source: Eur Respir J 2015; 45: 869-871
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Rabe Klaus F.. Treatment of COPD and the TOnado trial: a tempest in a teapot?. Eur Respir J 2015; 45: 869-871

Member's Comments

No comment yet.

Related content which might interest you: COPD: Still a Cinderella? Source: Eur Respir J 2003; 22: Suppl. 45, 67s Year: 2003 Optimising bronchodilator therapy in COPD: Who, why and when? Source: International Congress 2019 – Personalised medicine in COPD: Matching the patient needs with the right care Year: 2019 Chronic breathlessness: time for Cinderella to go to the ball! Source: Eur Respir J, 52 (3) 1801452; 10.1183/13993003.01452-2018 Year: 2018 Prescribing exercise in advanced COPD: Training smart, not just hard! Source: Annual Congress 2012 - The best posters in pulmonary rehabilitation and chronic care Year: 2012 COPD: more treatments but no cure? Source: Annual Congress 2011 - The European Respiratory Review 2010 updates: whats hot in pulmonary medicine? Year: 2011 What are common COPD symptoms in a real-life setting? The German DACCORD registry Source: International Congress 2014 – COPD markers Year: 2014 COPD in farmers: what have we learnt? Source: Eur Respir J 2016; 47: 16-18 Year: 2016 The most beautiful COPD chart in the world: all together to end COPD! Source: Eur Respir J, 54 (6) 1902047; 10.1183/13993003.02047-2019 Year: 2019 "Trial-skilled" patients: How big the improvement in cooperation? Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases Year: 2013 Late Breaking Abstract - Masitinib in severe asthma: Results from a randomized, phase 3 trial Source: Virtual Congress 2020 – ALERT: Asthma in adults and children Year: 2020 Late Breaking Abstract - RECEIVER trial: sustained use and improved outcomes with digitally supported COPD co-management Source: Virtual Congress 2021 – E-health for COVID-19 Year: 2021 Comparison of an innovative multi-dose inhaler with the attributes of an 'ideal' inhaler: A multicentre randomised controlled trial (RCT) Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Late Breaking Abstract - Telerehabilitation compared to centre-based pulmonary rehabilitation: a randomised controlled equivalence trial. Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation Year: 2020 Do Beta-blockers Prevent Acute Exacerbations of COPD? – results of a randomized clinical trial Source: ERS Webinar 2019: Do Beta-blockers Prevent Acute Exacerbations of COPD? – results of a randomized clinical trial Year: 2019 Late Breaking Abstract - A cluster-randomized trial of a nurse-led advance care planning session in patients with COPD and their loved ones Source: International Congress 2018 – Latest advances in pulmonary rehabilitation assessment and content Year: 2018 Predicting the clinical outcome in COPD:Who fares thebest-BODE,DOSE or ADO Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 Late Breaking Abstract: Pulmonary rehabilitation in COPD: Effects of two aerobic exercise intensity in patient-centered outcomes – A randomized study Source: Annual Congress 2010 - Physical activity methodology assessment and clinical consequences Year: 2010